LFKRI Seminar Series

  • 2018 Seminars

    Thursday, October 18, 2018 - 11AM
    “In vitro studies of erythropoiesis”
    Ashley Toye, PhD
    Principal Investigator, UK NHS-Blood & Transplant, and Senior Lecturer in Erythrocyte Biology, Department of Biochemistry, University of Bristol, UK

    Thursday, October 11, 2018 - 11AM
    “Thrombopoietic Agents in 2018: Ten Years Later”
    James Bussel, MD
    Professor Emeritus of Pediatrics, Weill Cornell Medical School, New York

    Thursday, October 4, 2018 - 11AM
    “Exploring the role of TAM (Tyro3_Axl_Mertk) receptors as a novel innate immune checkpoint in cancer immunotherapy" 
    Hind Medyouf, PhD
    Group Leader, Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany

    Thursday, September 13, 2018 - 11:30AM
    "Blood Center Considerations for Cellular Product Collections and Distribution"
    Robert J. Tressler PhD
    Vice President of Laboratories at San Diego Blood Bank

    Thursday, September 6, 2018 - 11AM
    “Modeling HIV pathogenesis, prevention and novel  therapies in humanized mice
    Ramesh Akkina, DVM, PhD
    Professor, Department of Microbiology, Immunology and Pathology, Colorado State University

    Wednesday, August 29, 2018 - 1PM
    "Setting up biobanks and translation research services in academia; experiences and challenges"
    Hassana Fathallah, PhD
    Director, Clinical Trials Scientific Affairs, ACM Global Laboratories, Rochester, New York

    WEDNESDAY, AUGUST 22, 2018 - 1PM
    “The role of CDMO's in the commercialization of cell therapy"
    Ruud Hulspas, PhD
    Founder, Cellular Technologies Bio-consulting, LLC, Rockville, MD 

    MONDAY, JULY 9, 2018 - 11AM
    "Pulmonary Inflammation in Sickle Cell Disease"
    Jeffrey A. Glassberg, M.D.
    Associate Professor of Hematology and Medical Oncology, and Emergency Medicine, Mount Sinai School of Medicine, New York

    THURSDAY, JUNE 14, 2018 - 11AM
    “Apheresis Collection for T cell Manufacturing: What’s in the bag and why do we care?”

    Andrew D. Fesnak, MD
    Assistant Professor, Director, Manufacturing, Clinical Cell and Vaccine Production Facility, University of Pennsylvania

    FRIDAY, APRIL 20, 2018 - 12PM
    "Patient Blood Management in Sickle Cell Disease"
    France Pirenne, MD, PhD
    Medical and Scientific Director, Etablissement Français du Sang, Créteil, Professor of Hematology, Institut Mondor de Recherche Biomédicale, lNSERM

    FRIDAY, MARCH 30, 2018 - 11AM 
    "Barriers and Facilitators to Potential Future Biomedical HIV Prevention Products in Transgender and Cisgender Women" 
    Christine Rael, PhD
    Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies, Columbia University

    THURSDAY, FEBRUARY 22, 2018 - 11AM
    "Role of Tissue Factor in Hemostasis, Thrombosis and Viral Infections"
    Nigel Mackman, PhD, FAHA
    John C. Parker
    Distinguished Professor of Medicine, Co-Director of the Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill


  • 2017 Seminars

    MONDAY, DECEMBER 4, 2017 - 11AM
    "Armored Chimeric Antigen Receptor (CAR) T Cells for Solid Tumor Malignancies"

    Oladapo Yeku, MD, PhD
    Medical Oncology Fellow, Memorial Sloan Kettering Cancer Center

    THURSDAY, NOVEMBER 30, 2017 - 11AM
    "Type 1 Interferons Promote Alloimmune Responses to Transfused RBC Antigens"
    David Gibbs, MD, PhD
    Transfusion Medicine/Blood Bank Fellow, Department of Laboratory Medicine, Yale University

    TUESDAY, NOVEMBER 28, 2017 - 11AM
    "Stem Cell-Derived Megakaryocytes Tool for Translational Research and Source of Cellular Therapies"

    Camelia Iancu-Rubin, PhD
    Associate Professor, Scientific Director, Hematological Malignancies Tissue Bank, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

    MONDAY, NOVEMER 20, 2017 - 11AM
    "Investigations into the AML Cell Surfaceome"

    Fabiana Perna, MD, PhD
    Senior Research Scientist, Memorial Sloan Kettering Cancer Center, New York

    THURSDAY, November 16, 2017 - 11AM
    "Insights into Immune Defects in Rag-deficiency and Stem Cell Collections for Gene Therapy in Sickle Cell Anemia"

    John Manis, MD
    Associate Director of Transfusion Medicine, Boston Children's Hospital, Harvard Medical School

    THURSDAY, OCTOBER 12, 2017 - 11AM
    "Heterogeneity Assays and Platelet Lysate: Challenges and Chances for Stem Cell Therapies Development"

    Richard Schaefer, MD
    Head of Department Cell Therapeutics & Cell Processing, German Red Cross, Goethe-University Hospital, Frankfurt, Germany

    THURSDAY, SEPTEMBER 7, 2017 - 11AM
    "Exploring the Human Microbiome"

    Tao Ding, PhD
    Postdoctoral Researcher, Department of Biology, Center for Genomics and Systems Biology, New York University

    MONDAY, AUGUST 21, 2017 - 11AM
    "Inflammasomes and Danger Signals during Infection by Intracellular Pathogens"
    David M. Ojcius, PhD
    Professor and Chair, Department of Biomedical Sciences, University of the Pacific,Arthur A. Dugoni School of Dentistry

    MONDAY, JULY 24, 2017 - 2PM
    "Inflammatory Modulation of the Bone Marrow Hematopoietic Niche"
    Leslie E. Silberstein, MD
    Director, Joint Program in Transfusion Medicine, Professor, Harvard Medical School

    THURSDAY, JULY 20, 2017 - 11AM
    "Dickkopf-1: The Wnt Antagonist Becomes a Novel Immunomodulator"
    Wook-Jin Chae, PhD
    Associate Research Scientist, Department of Immunobiology, Yale University School of Medicine

    MONDAY, JULY 17, 2017 - 1PM
    “Making Platelets In Vitro from Pluripotent Stem Cells: Going Beyond Transfusion and Blood Clotting”
    Cedric Ghevaert, MD, PhD
    Consultant Hematologist, Senior Lecturer in Transfusion Medicine, Department of Hematology, University of Cambridge, UK

    THURSDAY, MAY 18, 2017 - 11AM
    “The Mechanism of Action of Anti-D in Preventing Hemolytic Disease of the Fetus and Newborn: What Do We Really Know?”
    Alan H. Lazarus, PhD
    Scientist, St. Michael's Hospital and Canadian Blood Services, Professor of Medicine, University of Toronto

    WEDNESDAY, APRIL 5, 2017 - 1PM
    “Genetics and Metabolomics of Blood Storage”
    James C. Zimring, MD, PhD
    Director and Chief Scientific Officer, BloodworksNW Research Institute, Professor, Department of Lab Medicine and Department of Medicine, University of Washington School of Medicine

    THURSDAY, MARCH 2, 2017 - 11AM
    “Insights into ZIKV Epidemiology, Diagnostics and Pathogenesis from Studies of Blood Donors and Recipients”

    Michael Busch, MD, PhD
    Director and VP, Research and Scientific Affairs, Blood Systems Research Institute

    THURSDAY, FEBRUARY 16, 2017 - 11AM
    “Engineering of Complex Tissues - New Possibilities for Drug Development and Regenerative Medicine”
    Jan Hansmann, PhD
    Group Leader, University Hospital of Würzburg, Fraunhofer Institute of Interfacial Engineering and Biotechnology


Want more information?

Email: TDeVard@nybloodcenter.org
Office: (212) 570-3136